Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06360068
What this trial is testing

A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Qiong Fu 20
Testing effectiveness (Phase 2)Study completedNCT02955615
What this trial is testing

ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Iltoo Pharma 100
Not applicableLooking for participantsNCT07175285
What this trial is testing

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb 223
Not applicableUnknownNCT00671047
What this trial is testing

The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study

Who this might be right for
Systemic Lupus Erythematosus
XDx 1,000
Not applicableNot Yet RecruitingNCT07716462
What this trial is testing

Home-Based High-Intensity Interval Training in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErthematosusFatigueExercise Training
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Ended earlyNCT05123586
What this trial is testing

A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Eli Lilly and Company 85
Testing effectiveness (Phase 2)Ended earlyNCT00732940
What this trial is testing

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 56
Post-approval studies (Phase 4)Ended earlyNCT03920059
What this trial is testing

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chulalongkorn University 2
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Not applicableNot Yet RecruitingNCT07136337
What this trial is testing

The Diagnostic Utility of T Immunoglobulin G and T Immunoglobulin M Biomarkers in Patients With Systemic Lupus Erythematosus Disease : Associations With Disease Activity and Damage

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 80
Post-approval studies (Phase 4)UnknownNCT03214731
What this trial is testing

Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University 90
Testing effectiveness (Phase 2)Study completedNCT04925934
What this trial is testing

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

Who this might be right for
Lupus Erythematosus, Systemic
Amgen 214
Large-scale testing (Phase 3)Ended earlyNCT00368264
What this trial is testing

TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Medical University of Vienna 1
Testing effectiveness (Phase 2)WithdrawnNCT00752999
What this trial is testing

Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Rigel Pharmaceuticals
Large-scale testing (Phase 3)WithdrawnNCT04060888
What this trial is testing

Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT03845517
What this trial is testing

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Pfizer 350
Not applicableNot Yet RecruitingNCT07805863
What this trial is testing

Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Assiut University 90
Not applicableStudy completedNCT07481214
What this trial is testing

Lupus Walking Intervention to Address Fatigue/Quality of Life

Who this might be right for
System Lupus Erythematosus(SLE)
University of California, San Francisco 101
Early research (Phase 1)Not Yet RecruitingNCT07358988
What this trial is testing

KN5501 Cell Injection for Refractory SLE(CLEAR)

Who this might be right for
Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD 36
Not applicableUnknownNCT03728231
What this trial is testing

Disease Activity in RA and SLE Patients and Its Relation to Muscle Performance,Fatigue and Blood Parameters

Who this might be right for
Rheumatic Diseases
Assiut University 150
Next Page